Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
RTNominal down15.760 -0.040 (-0.253%)

28/01/2021 14:31

{I-bank focus}BOCI lifts China Life (02628) to HK$23.3

[ET Net News Agency, 28 January 2021] BOCI Research lifted its target price for China
Life (02628) to HK$23.3 from HK$21.6 due to recent RMB appreciation and maintained its
"buy" rating.
The research house expects the 4Q 2020 first-year premium (FYP) growth (including
premiums of short-term insurance business) to be mild at 7.4% for China Life, while the
new business value (NBV) margin is expected to marginally fall, which brings the FY2020
NBV growth to 1.8%.
China Life is expected to see fewer downside risks on NBV margins in the increasingly
intense competition of the 2021 jumpstart campaign, due to its consistent strategy across
years. China Life's FYP growth is also expected to be mild in FY2021.
BOCI expects China Life's NBV margins to gradually improve, which will lead to the NBV
growth of 14%/15%/15% over FY2021-23 respectively. (KL)

Remark: Real time quote last updated: 13/04/2021 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2021 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.